Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6408 posts found.

FDA approves Surgvision’s Explorer Air II device

March 21, 2023 Medical Communications

Medical technology company Surgvision has announced that it has received FDA 510(k) approval for its Explorer Air II device. It …
News

AstraZeneca and MSD announce MHRA marketing authorisation of Lynparza combination therapy

March 20, 2023 Medical Communications

AstraZeneca and MSD have announced that the MHRA has granted marketing authorisation for Lynparza (olaparib) in the UK, when used …
News

Oxford Nanopore and 4bases collaborate on kit for BRCA1 and BRCA2 gene analysis

March 20, 2023 Medical Communications

Oxford Nanopore Technologies and Swiss company 4bases have announced a collaboration making 4bases kits with Oxford Nanopore’s sequencing technology. These …
News

FDA approves Novartis’ Tafinlar and Mekinist combination

March 17, 2023 Medical Communications

The FDA has approved Novartis’ combination therapy, Tafinlar (dabrafenib) and Mekinist (trametinib) for the treatment of BRAF V600E low-grade glioma …
News

CANbridge Pharmaceuticals reports positive long-term data for glioblastoma multiforme drug

March 17, 2023 Medical Communications

Chinese biopharmaceutical company CANbridge Pharmaceuticals has announced positive long-term follow-up data from its clinical studies into a glioblastoma multiforme (GBM) …
News

Great Ormand Street Hospital enters commercial agreement with Leucid Bio

March 16, 2023 Medical Communications

Leucid Bio and Great Ormand Street Hospital NHS Foundation Trust (GOSH) have entered a commercial agreement to manufacture Leucid’s lead …
News

Bristol Myers Squibb works with SpaceX to study biomanufacturing in space

March 16, 2023 Medical Communications

It was announced last week that the SpaceX Dragon spacecraft will make its journey to the International Space Station (ISS) …
News

Cough medicines containing pholcodine withdrawn across UK

March 15, 2023 Medical Communications

Some cough syrups being sold behind the counter at pharmacies are being withdrawn due to safety concerns surrounding potential allergies …
News

FDA amends EUA of Pfizer-BioNTech COVID-19 vaccine for paediatric use

March 15, 2023 Medical Communications

Yesterday, the FDA announced that it has amended the Emergency Use Authorization (EUA) for the Pfizer-BioNTech bivalent COVID-19 Vaccine. The …
News

BlueRock Therapeutics collaboration over Parkinson’s disease digital health technology

March 15, 2023 Medical Communications

Clinical stage biopharmaceutical company BlueRock Therapeutics has announced a collaboration with Rune Labs and Emerald Innovations. It will look at …
News

US bill pushes Medicare and Medicaid categories for prescription digital therapeutics

March 14, 2023 Medical Communications

Both the US House of Representatives and Senate are considering a bill which would encourage the adoption of prescription digital …
News

Nasal spray that relieves migraines in minutes approved by FDA

March 13, 2023 Medical Communications

Pfizer is planning to launch a fast-acting nasal spray that can relieve pain from migraines in as little as 15 …
News

Horizon Therapeutics announces real-world treatment results for Dysthyroid Optic Neuropathy drug

March 13, 2023 Medical Communications

Biopharma company Horizon Therapeutics has announced real-world treatment results for its Thyroid Eye Disease (TED) drug in patients with Dysthyroid …
News

Biotech centre focusing on gene therapies opens in Bristol, UK

March 10, 2023 Medical Communications

A new state-of-the-art facility named the Clinical Biotechnology Centre (CBC) is opening in Bristol, UK. It cost approximately £10m to …
News

FDA committee supports Roche’s lymphoma treatment

March 10, 2023 Medical Communications

 A committee at the FDA have voted in favour of Roche’s Polivy antibody drug targeting untreated diffuse large B cell …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026